Dual action drug treatment for aggressive brain tumours
IHMRI and UOW researchers publish new findings on a potential new drug to treat glioblastoma, the most aggressive form of brain cancer.
Magnified Justin Yerbury Travel Scholarships winners return home
Dr Rebecca San Gil, Natalie Guthrie and René Jeżewski share their experiences of attending the 29th International Symposium on ALS/MND in Glasgow.
IHMRI researcher and MND advocate named Citizen of the Year
Professor Justin Yerbury has been named 2019 Australia Day Citizen of the Year by Wollongong City Council.
IHMRI researcher wins funding for study on diet and Multiple Sclerosis
Dietitian Dr Yasmine Probst is researching whether a balanced diet can reduce the symptoms of Multiple Sclerosis.
Fundraising efforts continue for VWMD research at IHMRI
It is less than two months until the annual Great Illawarra Walk and for the second year, all money raised will go towards research into Vanishing White Matter Disease.
MND discovery has implications for copper based drugs
IHMRI researchers have found that copper may not protect all motor neurone disease causing mutants in the SOD1 gene.
Project targets antibiotic resistant bacteria
Dr Andrew Robinson is the chief investigator for a research project on antibiotic resistant bacteria that has received funding from the NHMRC for 2019.
PhD candidate bound for Antarctic voyage
Claudia Kielkopf will depart for a three-week voyage to the Antarctic as part of the Homeward Bound leadership program for women in STEMM.
IHMRI researchers thank Illawarra Cancer Carers
IHMRI and UOW Advancement hosted an afternoon tea to thank the Illawarra Cancer Carers for their continuing support of local cancer research.
Professor Justin Yerbury wins MND research grant for 2019
Professor Justin Yerbury has been awarded the Dr Paul Brock MND Research Grant.